{"title":"骨髓肉芽肿:一定是肺结核吗?","authors":"Erna Ahsan, Shalini Singh, Saurabh Kumar Gautam, Harish Chandra, Priyavadhana Balasubramanian, Arvind Kumar Gupta, Neha Singh","doi":"10.1007/s12308-025-00647-5","DOIUrl":null,"url":null,"abstract":"<p><p>Granulomas in a bone marrow biopsy are like gold dust. Numerous studies have reported that the incidence of granulomas in bone marrow biopsies ranges from 0.3 to 2.2%. In developing countries such as India, tuberculosis is the most common cause of bone marrow granulomas; nonetheless, the etiologic spectrum includes a broad range of disorders. To better understand granulomatous inflammation in the bone marrow and prevent its misinterpretation, this study aims to highlight the variety of disorders, including infectious and non-infectious causes, that are linked to this finding. This is a retrospective study which was conducted in the Department of Pathology and Laboratory Medicine at All India Institute of Medical Sciences, Rishikesh. Bone marrow biopsies with granulomatous inflammation reported over a period of 3 years, from 2022 to 2024, were reviewed for their clinical and laboratory features and included in this study. We identified 22 cases among 3485 bone marrow biopsies, representing an incidence of 0.63% in the series. Among the 22 patients, the most common etiology was infectious (59.1%), followed by malignancy (36.34%), and sarcoidosis (4.5%). Marrow granulomas should prompt a thorough investigation into the underlying cause. It is hoped that this article would help in guiding the investigation for potential causes.</p>","PeriodicalId":51320,"journal":{"name":"Journal of Hematopathology","volume":"18 1","pages":"32"},"PeriodicalIF":0.6000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Granulomas in bone marrow: is it always tuberculosis?\",\"authors\":\"Erna Ahsan, Shalini Singh, Saurabh Kumar Gautam, Harish Chandra, Priyavadhana Balasubramanian, Arvind Kumar Gupta, Neha Singh\",\"doi\":\"10.1007/s12308-025-00647-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Granulomas in a bone marrow biopsy are like gold dust. Numerous studies have reported that the incidence of granulomas in bone marrow biopsies ranges from 0.3 to 2.2%. In developing countries such as India, tuberculosis is the most common cause of bone marrow granulomas; nonetheless, the etiologic spectrum includes a broad range of disorders. To better understand granulomatous inflammation in the bone marrow and prevent its misinterpretation, this study aims to highlight the variety of disorders, including infectious and non-infectious causes, that are linked to this finding. This is a retrospective study which was conducted in the Department of Pathology and Laboratory Medicine at All India Institute of Medical Sciences, Rishikesh. Bone marrow biopsies with granulomatous inflammation reported over a period of 3 years, from 2022 to 2024, were reviewed for their clinical and laboratory features and included in this study. We identified 22 cases among 3485 bone marrow biopsies, representing an incidence of 0.63% in the series. Among the 22 patients, the most common etiology was infectious (59.1%), followed by malignancy (36.34%), and sarcoidosis (4.5%). Marrow granulomas should prompt a thorough investigation into the underlying cause. It is hoped that this article would help in guiding the investigation for potential causes.</p>\",\"PeriodicalId\":51320,\"journal\":{\"name\":\"Journal of Hematopathology\",\"volume\":\"18 1\",\"pages\":\"32\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hematopathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12308-025-00647-5\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hematopathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12308-025-00647-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Granulomas in bone marrow: is it always tuberculosis?
Granulomas in a bone marrow biopsy are like gold dust. Numerous studies have reported that the incidence of granulomas in bone marrow biopsies ranges from 0.3 to 2.2%. In developing countries such as India, tuberculosis is the most common cause of bone marrow granulomas; nonetheless, the etiologic spectrum includes a broad range of disorders. To better understand granulomatous inflammation in the bone marrow and prevent its misinterpretation, this study aims to highlight the variety of disorders, including infectious and non-infectious causes, that are linked to this finding. This is a retrospective study which was conducted in the Department of Pathology and Laboratory Medicine at All India Institute of Medical Sciences, Rishikesh. Bone marrow biopsies with granulomatous inflammation reported over a period of 3 years, from 2022 to 2024, were reviewed for their clinical and laboratory features and included in this study. We identified 22 cases among 3485 bone marrow biopsies, representing an incidence of 0.63% in the series. Among the 22 patients, the most common etiology was infectious (59.1%), followed by malignancy (36.34%), and sarcoidosis (4.5%). Marrow granulomas should prompt a thorough investigation into the underlying cause. It is hoped that this article would help in guiding the investigation for potential causes.
期刊介绍:
The Journal of Hematopathology aims at providing pathologists with a special interest in hematopathology with all the information needed to perform modern pathology in evaluating lymphoid tissues and bone marrow. To this end the journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, and occasional case reports in the fields of the pathology, molecular biology, and clinical features of diseases of the hematopoietic system.
The journal is the unique reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other diseases.
The journal is unique in its true international character. Especially in the field of hematopathology it is clear that there are huge geographical variations in incidence of diseases. This is not only locally relevant, but due to globalization, relevant for all those involved in the management of patients.